Eyenovia (EYEN) Revenue & Revenue Breakdown
Eyenovia Revenue Highlights
Latest Revenue (Y)
$57.34K
Latest Revenue (Q)
$28.09K
Eyenovia Revenue by Period
Eyenovia Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $57.34K | 1414.02% |
2023-12-31 | $3.79K | 100.00% |
2022-12-31 | - | -100.00% |
2021-12-31 | $14.00M | 600.00% |
2020-12-31 | $2.00M | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | - |
Eyenovia generated $57.34K in revenue during NA 2024, up 1414.02% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Eyenovia Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-12-31 | $28.09K | 1628.80% |
2024-09-30 | $1.63K | -92.82% |
2024-06-30 | $22.63K | 353.13% |
2024-03-31 | $4.99K | 92.85% |
2023-12-31 | $2.59K | 116.11% |
2023-09-30 | $1.20K | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $10.00M | 100.00% |
2021-09-30 | - | -100.00% |
2021-06-30 | $2.00M | - |
2021-03-31 | $2.00M | - |
2020-12-31 | $2.00M | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | - |
Eyenovia generated $28.09K in revenue during Q4 2024, up 1628.80% compared to the previous quarter, and up 2344.99% compared to the same period a year ago.
Eyenovia Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
EYPT | EyePoint Pharmaceuticals | $43.27M | $11.59M |
ETON | Eton Pharmaceuticals | $39.01M | $11.65M |
IRD | Opus Genetics | $10.99M | $4.30M |
EYEN | Eyenovia | $57.34K | $28.09K |
CRVS | Corvus Pharmaceuticals | - | - |
RVPH | Reviva Pharmaceuticals | - | - |
SLS | SELLAS Life Sciences Group | - | - |
LPTX | Leap Therapeutics | - | - |
CLSD | Clearside Biomedical | - | - |